These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 18084873)
1. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition. Ushiroyama T; Ikeda A; Ueki M J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873 [TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. Kiev A; Feiger A J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424 [TBL] [Abstract][Full Text] [Related]
3. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Stahl SM; Entsuah R; Rudolph RL Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062 [TBL] [Abstract][Full Text] [Related]
5. A comparison of fluvoxamine and fluoxetine in the treatment of major depression. Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909 [TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients. Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder. Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239 [TBL] [Abstract][Full Text] [Related]
8. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105 [TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880 [TBL] [Abstract][Full Text] [Related]
10. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. Zanardi R; Franchini L; Serretti A; Perez J; Smeraldi E J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. Mundo E; Bianchi L; Bellodi L J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005 [TBL] [Abstract][Full Text] [Related]
12. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine. Chiu HJ; Hong CJ; Chan CH Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):418-23. PubMed ID: 8803304 [TBL] [Abstract][Full Text] [Related]
17. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients? Kertzman S; Vainder M; Reznik I; Gotzlav Y; Weizman A; Kotler M; Iancu I Int Clin Psychopharmacol; 2012 May; 27(3):134-41. PubMed ID: 22415223 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group. Haffmans PM; Timmerman L; Hoogduin CA Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975 [TBL] [Abstract][Full Text] [Related]
20. Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K; Perry CM CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]